ICICIDirect has recommended hold rating on Sun Pharma with a target price of Rs 845 in its research report dated February 15, 2016.
Edelweiss is bullish on Sun Pharma and has recommended buy rating on the stock with a target price of Rs 920 in its research report dated December 22, 2015.
For SAMVAT 2072, AB Money recommends a portfolio of 15 quality businesses/companies, which are mix of cyclicals, new emerging sectors and consumption with strong earnings growth momentum. Expect these stocks to deliver returns in the range of 20-25% over next 6-12 months, says the report.
Reliance Securities has a neutral view on Sun Pharmaceuticals, in its November 04, 2015. research report.
Mehta Equities has come out with its report on stock ideas for 2012-13.
Fairwealth Securities has come out with its six investment ideas for the year 2012. Axis Bank, Ashok Leyland (AL), Bajaj Electricals (BEL), KPIT Cummins, Jindal Steel and Power (JSPL) and Shasun Pharma are the few portfolio bets for the current year 2012.
Shasun Pharmaceuticals touched an intraday high of Rs 84.85 and an intraday low of Rs 78.45. At 09:39 hrs the share was quoting at Rs 84.10, up Rs 5.65, or 7.20%.